Cleanroom Whitepapers and Case Studies

  1. Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators 4/28/2025

    Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.

  2. Validation And Qualification Approach In New Annex 1 Revision 2/21/2025

    The new Annex 1 revision emphasizes validation and qualification for sterile drug production. Ensure product quality and contamination control by learning about in-depth requirements for premises and equipment.

  3. A Powerful Non-Destructive Tool For Tablet Characterization 10/6/2025

    Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.

  4. Safety, Containment, And Analysis Of Highly Potent Compounds 5/16/2024

    Explore a comprehensive overview of the challenges, requirements, and best practices for safely working with highly potent compounds in drug development and manufacturing.

  5. Antibody-Drug Conjugates – Catalysts For Chemistry 5/16/2024

    Review the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development.

  6. Treatment Plant Maintains Service During Infrastructure Upgrade Using Xylem Rental Bypass 11/12/2025

    To move forward with long-overdue infrastructure upgrades, Nodra AB needed a wastewater bypass solution capable of lifting up to 3,000 liters per second into its Slottshagens treatment plant. Xylem’s Rental Solutions team set up a turnkey wastewater bypass station in a little over three weeks.

  7. Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap 7/23/2025

    As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.

  8. Manufacturing Of Cytotoxic And Non-Cytotoxic Drugs In A Multiproduct Facility 10/16/2024

    The experience and expertise of the CMO is crucial to avoid the risk of cross-contamination of the drug product, as failures or weaknesses in this process can pose risk to the end-user.

  9. The Role Of Extractables Data In The Adoption Of Single-Use Systems 8/29/2024

    Explore guidance for evaluating single-use systems for extractables and leachables, and learn how supplier-provided single-use system extractables data can save both time and resources.

  10. Vassar WWTP Eliminates Rags To Protect Equipment, Biosolids Quality 4/4/2025

    The Vassar wastewater treatment plant (WWTP) in Michigan, confronted persistent challenges from non-dissolvable solids by adopted Duperon's Dual Auger System (DAS) to address these issues effectively.